RXi Pharmaceuticals Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.25 |
Market Cap |
$6.43 M |
Shares Outstanding |
4.38 M |
Public Float |
3.64 M |
Address |
257 Simarano Drive Marlborough Massachusetts 01752 United States |
Employees | - |
Website | http://www.rxipharma.com |
Updated | 09/14/2018 |
RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA. |